(Q84401609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Marjanka J J M Mingels

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Thijs Roelofsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jeroen A W M van der Laak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Joanne A de Hullu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Maaike A P C van Ham

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Leon F A G Massuger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Mijke Bol

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

16 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

88-93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens fromBRCA1 heterozygotes

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Histopathologic Features of Ovaries at Increased Risk for Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Tubal ligation and risk of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Society of Gynecologic Oncologists Clinical Practice Committee Statement on Prophylactic Salpingo-oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.015

10.1016/J.YGYNO.2012.06.015

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22710074%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference